Metraipolis › archive › dc_4bc874ff2903

Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications — Europe PMC PMID:40963965

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40963965
DOI
10.3389/fped.2025.1617579
License (as archived)
solo-consultazione
Archived
2026-11-10T04:22:31.547Z
SHA-256 of the archived text
beb3bcd8f686bc319ec47380ecb126f520947d8ccd5c9bf5b33b0acee7def36b
Stable URL of this page
https://metraipolis.com/documento/dc_4bc874ff2903

How to cite

Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications — Europe PMC PMID:40963965 — Europe PMC (en), https://europepmc.org/article/MED/40963965 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4bc874ff2903 (Metraipolis archive dc_4bc874ff2903, sha256 beb3bcd8f686bc319ec47380ecb126f520947d8ccd5c9bf5b33b0acee7def36b)
BibTeX
@misc{dc4bc874ff2903,
  title = {Adherence to recombinant human growth hormone therapy in children: influencing factors and clinical implications — Europe PMC PMID:40963965},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40963965},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4bc874ff2903; sha256 beb3bcd8f686bc319ec47380ecb126f520947d8ccd5c9bf5b33b0acee7def36b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40963965. Agents can read the archived copy with the MCP tool read_document.